[1] Gustot T, Stadlbauer V, Laleman W, et al. Transition to decompensation and acute-on-chronic liver failure:role of predisposing factors and precipitating events[J].J Hepatol, 2021, 75(Suppl 1):S36-S48. [2] Cai Y J, Dong J J, Dong J Z, et al. A nomogram for predicting prognostic value of inflammatory response biomarkers in decompensated cirrhotic patients without acute-on-chronic liver failure[J]. Aliment Pharmacol Ther, 2017, 45(11): 1413-1426. [3] Zanetto A, Pelizzaro F, Campello E, et al. Severity of systemic inflammation is the main predictor of ACLF and bleeding in individuals with acutely decompensated cirrhosis[J]. J Hepatol, 2023, 78(2):301-311. [4] Giri S, Anirvan P, Chaudhary M, et al. Impact of nutritional status on the outcome of transjugular intrahepatic portosystemic shunt in patients with cirrhosis: a systematic review[J]. Br J Radiol, 2024, 97(1154):331-340. [5] Islam M M, Satici M O, Eroglu S E. Unraveling the clinical significance and prognostic value of the neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, systemic immune-inflammation index, systemic inflammation response index, and delta neutrophil index: an extensive literature review[J]. Turk J Emerg Med, 2024, 24(1):8-19. [6] Yang C K, Huang K T, Qin W, et al. Prognostic value of geriatric nutritional risk index and prognostic nutritional index in hepatocellular carcinoma[J].Clin Nutr ESPEN, 2024, 59:355-364. [7] Yan L, Nakamura T, Casadei-Gardini A, et al. Long-term and short-term prognostic value of the prognostic nutritional index in cancer: a narrative review[J].Ann Transl Med, 2021, 9(21):1630. [8] Zhang S, Wang H, Chen S, et al. Prognostic nutritional index and prognosis of patients with coronary artery disease: a systematic review and meta-analysis[J]. Front Nutr, 2023, 10:1114053. [9] 中华医学会消化病学分会.中国肝硬化临床诊治共识意见[J]. 临床肝胆病杂志, 2023, 39(9): 2057-2073. [10] Jalan R, Pavesi M, Saliba F, et al. The CLIF Consortium acute decompensation score (CLIF-C ADs) for prognosis of hospitalised cirrhotic patients without acute-on-chronic liver failure[J]. J Hepatol, 2015, 62: 831-840. [11] Engelmann C, Clària J, Szabo G, et al. Pathophysiology of decompensated cirrhosis: portal hypertension, circulatory dysfunction, inflammation, metabolism and mitochondrial dysfunction[J]. J Hepatol,2021,75 Suppl 1(Suppl 1):S49-S66. [12] Trebicka J, Fernandez J, Papp M, et al. The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology[J]. J Hepatol, 2020,73(4): 842-854. [13] Trebicka J, Amoros A, Pitarch C, et al. Addressing profiles of systemic inflammation across the different clinical phenotypes of acutely decompensated cirrhosis[J]. Front Immunol, 2019,10:476. [14] Arroyo V, Angeli P, Moreau R, et al. The systemic inflammation hypothesis: towards a new paradigm of acute decompensation and multiorgan failure in cirrhosis[J]. J Hepatol, 2021, 74(3):670-685. [15] Bernsmeier C, Cavazza A, Fatourou E M, et al. Leucocyte ratios are biomarkers of mortality in patients with acute decompensation of cirrhosis and acute-on-chronic liver failure[J]. Aliment Pharmacol Ther, 2020, 52(5):855-865. [16] Angeli P, Claria J, Moreau R, et al. Albumin in decompensated cirrhosis: new concepts and perspectives[J].Gut, 2020, 69(6):1127-1138. [17] Baldassarre M, Naldi M, Zaccherini G, et al. Determination of effective albumin in patients with decompensated cirrhosis: clinical and prognostic implications[J]. Hepatology, 2021, 74(4):2058-2073. [18] Zhang Y, Xing Z, Zhou K, et al. The predictive role of systemic inflammation response index (SIRI) in the prognosis of stroke patients[J]. Clin Interv Aging, 2021, 16:1997-2007. [19] Zhang Y, Chen P, Zhang W, et al. Derivation and validation of a prognostic model for acute decompensated cirrhosis patients[J]. Patient Prefer Adherence, 2023, 17:1293-1302. [20] Valainathan S R, Xie Q, Arroyo V, et al. Prognosis algorithms for acute decompensation of cirrhosis and ACLF[J]. Liver Int,2025,45(3):e15927. |